Efficacy and tolerability of baclofen in a U.S. community population with alcohol use disorder: a dose-response, randomized, controlled trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and tolerability of baclofen in a U.S. community population with alcohol use disorder: a dose-response, randomized, controlled trial
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-22
DOI
10.1038/s41386-021-01055-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder
- (2019) Paola Maccioni et al. CNS DRUGS
- Baclofen for alcohol use disorder-a systematic meta-analysis
- (2018) T. Bschor et al. ACTA PSYCHIATRICA SCANDINAVICA
- Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis
- (2018) Abigail K. Rose et al. ADDICTION
- Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial
- (2018) Kirsten C. Morley et al. BRITISH JOURNAL OF PSYCHIATRY
- Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis
- (2018) Mimi Pierce et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction
- (2018) Valentina Vengeliene et al. PSYCHOPHARMACOLOGY
- Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial
- (2016) Esther M. Beraha et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence
- (2016) James C. Garbutt et al. JAMA Psychiatry
- Tolerability of High-dose Baclofen in the Treatment of Patients with Alcohol Disorders: A Retrospective Study
- (2015) Laurent Rigal et al. ALCOHOL AND ALCOHOLISM
- Epidemiology ofDSM-5Alcohol Use Disorder
- (2015) Bridget F. Grant et al. JAMA Psychiatry
- Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings
- (2014) Daniel E. Jonas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers
- (2014) Lorenzo Leggio et al. PSYCHOPHARMACOLOGY
- Gabapentin Treatment for Alcohol Dependence
- (2013) Barbara J. Mason et al. JAMA Internal Medicine
- Reduction of alcohol intake by the positive allosteric modulator of the GABAB receptor, rac-BHFF, in alcohol-preferring rats
- (2012) Barbara Loi et al. ALCOHOL
- Suppression of Alcohol Dependence Using Baclofen: A 2-Year Observational Study of 100 Patients
- (2012) Renaud de Beaurepaire Frontiers in Psychiatry
- Treating alcohol withdrawal with oral baclofen: A randomized, double-blind, placebo-controlled trial
- (2011) Jeffrey E. Lyon et al. Journal of Hospital Medicine
- Percentage of Subjects With No Heavy Drinking Days: Evaluation as an Efficacy Endpoint for AlcoholClinical Trials
- (2010) Daniel Falk et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Efficacy and Safety of Baclofen for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2010) James C. Garbutt et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More